IFN γMIGIP-10

Control Con Ab Anti IFN γ Anti MIG Anti IP-10

pg/m

g of

tota

l pro

tein

0

2000

4000

6000

8000

10000

12000

14000

Diluent CCL-21 treated (0.5 µg, 3 times/week)

*

*

*

* *

*

*

*

*

*: p < 0.01 compared to control antibody groupIFN γMIGIP-10

2

Figure 2